An Bras Dermatol:儿童雄激素性脱发:23例患者的临床特征、激素测定和代谢综合征危险因素的回顾性回顾

2022-09-09 医路坦克 MedSci原创

在儿童和青少年中,雄激素性脱发(AGA)的发生率比以前预期的更高,本文评估了患有AGA的儿童患者的人口学特征、病史和家族史、临床特征以及纤毛镜检查结果、雄激素和危险因素。

据报道,在儿童和青少年中,斑秃和毛躁症是最常见的脱发形式,但雄激素性脱发(AGA)的发生率比以前预期的更高。雄激素和遗传易感性在AGA的发展中都起作用,因此在没有雄激素水平异常的青春期前患者中不会出现这种情况。在上个世纪,肾上腺和青春期的开始已经转移到更年轻的年龄,最可能是由于高胰岛素饮食和环境荷尔蒙增加,以及性暴露。有人认为,儿童AGA的患病率随着这一人群在年轻时暴露于循环雄激素水平的增加而增加,这会导致遗传易感儿童AGA的早期发展。

由于AGA好发于成人,在儿科人群中通常不被充分认识,因此在文献中很少讨论。游离和总睾酮、脱氢表雄酮硫酸盐(DHEAS)和雄烯二酮是这些患者中最常被评估的雄激素。AGA本身已被报道与许多代谢相关疾病有关,如代谢综合征(METS)、心血管疾病(CVD)、胰岛素抵抗(IR)、高血压、血脂异常和成人肥胖。然而,在儿科AGA中,甲硫氨酸的存在及其危险因素尚未被研究过。

AGA是一个终生的遗传过程,也可能影响儿科人群。因此,了解该病的临床表现和潜在的相关激素和代谢异常对于及时诊断、适当的医疗干预和治疗是至关重要的。在这项回顾性研究中,我们评估了患有AGA的儿童患者的人口学特征、病史和家族史、临床特征以及纤毛镜检查结果、雄激素和危险因素。

方法:回顾分析儿童雄激素性脱发的临床资料。

16例青少年AGA患者、7例儿童AGA患者和23例儿童AGA患者的发病年龄、发病年龄和持续时间

观察到儿童雄激素性脱发的脱发模式。(A)女性青春期雄激素性脱发患者,头顶弥漫性变薄,额部发际线保持不变。(B)保留男性青春期雄激素性脱发患者的额部发际线,该脱发患者的头顶弥漫性变薄。

观察到儿童雄激素性脱发的脱发模式。(A)“圣诞树”型青春期雄激素性脱发的女性患者。(B)青春期雄激素性脱发男性患者的双颞叶、额顶和顶叶变薄。

儿童雄激素性脱发的支气管镜表现。(A和B),毛发直径多样性和单毛毛发皮脂单位。(A)卵泡周围变色(白色箭头)。(B)、波状头发(白色箭头)、圆形头发(黄色箭头)、虚线和逗号(黑色箭头)。

结果:23例患者中,女性12例,男性11例,平均年龄15.3±2.1岁。16例为青少年雄激素性脱发,7例为儿童期脱发。9名患者报告有家族病史,他们都有青春期雄激素性脱发。在3例青少年雄激素性脱发患者中发现高雄激素血症。最常见的脱发模式是冠部弥漫性变薄,但保留额部发际线,10例患者(43.5%),其中6例为男性。14名患者(60.9%)至少有一个代谢综合征危险因素。最常见的危险因素是肥胖或超重(47.8%),其次是胰岛素抵抗(21.7%)、空腹血糖升高(13%)、高血压(4.4%)和血脂异常(4.4%)。

结论:儿童雄激素性脱发常与代谢综合征危险因素相关。因此,儿童人群中的雄激素性脱发可能预示着一种未来的代谢综合征,需要准确和迅速的诊断,以便进行早期筛查和治疗。

文献来源: Özcan D,Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients.An Bras Dermatol 2022 Mar-Apr;97(2)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843013, encodeId=53cb1843013e5, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Nov 19 08:45:46 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662344, encodeId=5148166234497, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Wed Feb 08 08:45:46 CST 2023, time=2023-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248172, encodeId=4f6312481e224, content=不错 多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c406465747, createdName=ms9000000239634123, createdTime=Fri Sep 09 19:14:54 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432399, encodeId=b6de1432399dd, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 10 08:45:46 CST 2022, time=2022-09-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843013, encodeId=53cb1843013e5, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Nov 19 08:45:46 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662344, encodeId=5148166234497, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Wed Feb 08 08:45:46 CST 2023, time=2023-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248172, encodeId=4f6312481e224, content=不错 多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c406465747, createdName=ms9000000239634123, createdTime=Fri Sep 09 19:14:54 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432399, encodeId=b6de1432399dd, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 10 08:45:46 CST 2022, time=2022-09-10, status=1, ipAttribution=)]
    2023-02-08 丁鹏鹏
  3. [GetPortalCommentsPageByObjectIdResponse(id=1843013, encodeId=53cb1843013e5, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Nov 19 08:45:46 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662344, encodeId=5148166234497, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Wed Feb 08 08:45:46 CST 2023, time=2023-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248172, encodeId=4f6312481e224, content=不错 多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c406465747, createdName=ms9000000239634123, createdTime=Fri Sep 09 19:14:54 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432399, encodeId=b6de1432399dd, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 10 08:45:46 CST 2022, time=2022-09-10, status=1, ipAttribution=)]
    2022-09-09 ms9000000239634123

    不错 多学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1843013, encodeId=53cb1843013e5, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Nov 19 08:45:46 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662344, encodeId=5148166234497, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db925396819, createdName=丁鹏鹏, createdTime=Wed Feb 08 08:45:46 CST 2023, time=2023-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248172, encodeId=4f6312481e224, content=不错 多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c406465747, createdName=ms9000000239634123, createdTime=Fri Sep 09 19:14:54 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432399, encodeId=b6de1432399dd, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Sep 10 08:45:46 CST 2022, time=2022-09-10, status=1, ipAttribution=)]

相关资讯

Heart:复发性心内膜炎的临床特征和结局

复发性和首发性IE患者的住院和1年死亡率相似,但预后不良的预测因素相似。

Circ-Heart Fail:急性心肌梗死和心力衰竭相关心源性休克的临床特征、住院病程和1年结局比较

HF-CS患者较年轻,尽管心功率输出较低,肺毛细血管楔形压较高,但接受血管加压药或临时机械循环支持的可能性较小。

Crit Care:重症社区获得性肺炎和2型糖尿病患者死亡的临床特征及危险因素

与非糖尿病患者相比,伴有T2DM的SCAP患者的临床结局更差。列线图对医院死亡率具有良好的预测性能。

J Headache Pain:缺血性卒中后持续性头痛临床特征和与进展的相关因素

缺血性卒中引起的持续性头痛并不少见,经常导致药物滥用。由于卒中的其他严重后果,这个问题经常被忽视,但实际上,它对生活质量有相当大的影响。

≥70岁DLBCL患者的临床特征和生存结局,来自中国多中心研究

本研究是报告中国≥70岁 DLBCL 患者临床特征和生存结局的最大病例系列。老年DLBCL患者的治疗需要仔细评价毒性和获益,为此临床上需要一种预后模式,以优化老年 DLBCL 患者的治疗。

2013-2019年华中地区5569例小儿烧伤的流行病学和临床特征

所有年龄段的小儿烧伤在世界范围内都很普遍,对儿童构成了严重的健康威胁。本研究旨在调查华中地区小儿烧伤的临床特征和流行病学。